Clinical Trial Update: ACTinium in Castrate-RESistant Prostate Cancer After LUTEtium [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update describes a Phase 1/Phase 2 study of ACTinium in metastatic castration-resistant prostate cancer following prior LUTEtium therapy. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• ACTinium
• LUTEtium

Snippet

Sponsor: University College, London | Conditions: Metastatic Castration-resistant Prostate Cancer, Metastatic Prostate Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING